Jensen Huang Falls, Amodei Rises: Anthropic IPO Nearly 7x Oversubscribed as Wall Street Bets the Shovel Sellers Can Also Profit

Stock News07:14

When NVIDIA (NVDA) chief Jensen Huang was enduring a dramatic fall from grace last week, one of his company's most important chip customers was preparing to ascend into the top tier of American public companies — with what is expected to be the largest IPO in history.

This week's listing of Anthropic PBC not only means CEO Dario Amodei must fill the void left by Huang — once the AI industry's most important public face. It also demands that the company prove the AI gold rush has matured beyond the "selling shovels" phase. Wall Street's focus is shifting toward the companies that actually use the tools to make money — the very tools that let NVIDIA (NVDA) reach a $5.8 trillion market capitalization at its peak.

That requires patience from the investment community — which is known for its obsession with short-term results. According to Goldman Sachs analysts, Anthropic is not expected to achieve positive annual free cash flow until 2030; the AI company's cumulative spending commitments exceed $900 billion, extending out to 2045. And the future of data center expansion is tangled in circular deals — NVIDIA (NVDA) is providing financing to Anthropic and other major AI chip users — raising questions about whether the chipmaker's new leadership possesses Huang-style risk tolerance.

Not a Dollar More on Valuation

Amodei himself appears able to block out all the noise. On Friday, wearing his signature running shoes, white socks and blue blazer, he shared a stage with JPMorgan CEO Jamie Dimon for a roadshow at the bank's new headquarters in New York. In the audience sat prominent fund managers including Paul Singer, Bill Ackman and Ron Baron.

"We don't really care about exactly when — which month, which day, or under what market conditions we go public," Amodei told Dimon. He also said the best advice he received throughout the process was: "Never let your company be worth even one dollar more than it's actually worth."

Nearly 7x Oversubscribed, Hotter Than SpaceX

For Wall Street investors who have been trying to estimate what this frontier lab is actually worth, the IPO is not just a vote of confidence from Anthropic itself — it is an assurance that the entire AI trade will continue, even with a leadership change at the helm.

"This is extremely important because they may be the best indicator of the health of the AI ecosystem," said Angelo Zino, senior vice president and head of technology research at CFRA. "Their narrative on AI monetization is now as important as — or even more important than — NVIDIA's. After all, Jensen Huang is no longer there."

The AI lab is targeting a $1.4 trillion valuation in its initial public offering — below the $2 trillion rumored months ago, but far above the $1.1 trillion some on Wall Street floated at the trough of the recent tech selloff. Anthropic and some of its backers are seeking to raise as much as $90.4 billion through the IPO and a separate private placement — combined, that would exceed SpaceX's $75 billion base deal and become the largest listing ever.

Subscription enthusiasm is visible: according to people familiar with the matter, IPO orders have reached nearly 7 times the available shares, far hotter than SpaceX at the same stage. The only comparable offering is Snowflake's $3.9 billion IPO in 2020 — whose shares rose 112% on the first day. Anthropic declined to comment.

Monthly ARR Takes Center Stage: $10 Billion Added in a Single Month

For a company less than six years old, Anthropic's sales scale is already astonishing: as of October 31, its run-rate revenue reached $81 billion — an increase of $10 billion from the end of September. If it achieves that annualized figure, it would join an elite club, even surpassing analyst estimates for AI hardware giants like Intel and ASML.

"Public markets are grasping at straws trying to figure out AI demand, which is why everyone is watching the month-end ARR number," said Matt Witheiler, head of late-stage growth investing at Wellington Management, which holds Anthropic shares. "Public markets previously had no gauge for AI demand because these companies were all private. But as Anthropic becomes the first AI lab to list on public markets, all of that will change."

Anthropic's spending has not yet exhausted its resources — it holds more than $130 billion in cash and equivalents (after roughly $141 billion in cumulative funding). But that won't last long: of its spending commitments over the coming years, about $71 billion comes due before the end of September 2027.

"Intensifying price competition could make it harder to generate enough enterprise token consumption to absorb these infrastructure commitments while maintaining gross margins," said Mandeep Singh, an analyst at Bloomberg Intelligence.

Contrast With SpaceX: One Restrained, One All-In

Compared with the "story" SpaceX told IPO investors earlier this year, Anthropic is relatively restrained. Musk's clock company once counted its AI business's addressable market as $26.5 trillion out of a $28.5 trillion total addressable market — while that business generated just $818 million in revenue in the quarter before its IPO. Even so, investors still gave SpaceX a $1.77 trillion offering valuation.

There is another group of buyers waiting in line: passive funds. According to Bloomberg Intelligence analyst Deniz Besiroglu, if the valuation holds, Anthropic could be included in the Nasdaq 100 within about three weeks of listing; as for the S&P 500, it would take at least a year or longer.

For investors who have flocked to "shovel sellers" like NVIDIA (NVDA), backing Anthropic is almost the only choice: Anthropic's spending ultimately flows to chipmakers like NVIDIA (NVDA) and AMD — through compute contracts with infrastructure providers — and the chipmakers then plow enormous sums back into Anthropic, including a $26 billion private placement disclosed on the cover of its IPO filing.

But shadows cannot be avoided: tech stocks have been battered over the past month; after the midterm elections, Democrats control Congress and are hostile to the industry; and Huang has been ousted. Huang had been the key industry cheerleader since the AI boom began four years ago — until a series of extramarital affair reports (including a relationship with an alleged Chinese spy) surfaced, triggering NVIDIA's (NVDA) worst week since the April 2025 Trump tariff selloff and prompting Wall Street to reassess the future of AI.

This adds even more pressure on Anthropic: it must reignite bullish conviction in the technology. If the market begins turning to Amodei rather than Huang for reassurance, the contrast between the two would be stark: one a globe-trotting celebrity leader whose signature outfit is a Tom Ford black leather jacket, always sunny and optimistic in public; the other a low-key, contemplative co-founder prone to warning about AI's existential dangers to society.

The differences between the two companies became more explicit last week: according to people familiar with the matter, Anthropic excluded institutional investors from mainland China and Hong Kong from IPO subscriptions — whereas Huang was once eager to get his company's products into China and cultivate close ties with the country.

AI Barometer

Setting aside NVIDIA's (NVDA) internal problems, as investor focus shifts from "the chips and infrastructure needed to power AI" to "the companies building agents and chatbots" — the providers of the ultimate use case — Anthropic may be the more appropriate AI bellwether.

"The expectations are clear and very high. The question is whether the company can stay on the trajectory needed to meet them," said Mike Smith, head of growth equity investing at Allspring Global Investments. "Unfortunately, trillions of dollars rest on their shoulders. It's one of the proxy indicators for whether all of this holds together."

"Anthropic could become the most important company for public markets because it will become the face of 'AI commercialization,'" said Kim Forrest, chief investment officer at Bokeh Capital Partners. "All eyes should have been on the people using AI, using the chips, all along."

This week, all eyes will be on Anthropic. The underwriting syndicate led by Goldman Sachs and Morgan Stanley is expected to stop taking orders on Tuesday — ironically, the same day as NVIDIA's (NVDA) first earnings report and conference call without Huang at the helm. Given Anthropic's size, how shares are allocated and where pricing lands will be crucial for the entire market. After listing, Anthropic's quarterly earnings will become key to how the market and global economy understand "where progress stands."

"In my view, nothing is more important right now than watching the monetization of the infrastructure that has been built," said Smith of Allspring. "For this to work, they will have to generate more revenue in two to three years than anyone in history."

That is an absurdly high bar. But investors appear willing to bet that Amodei's dream will continue to come true — not just productivity gains for mundane business tasks, but grander ambitions.

"I hope we can prove the skeptics wrong: every disease you can think of — heart disease, Alzheimer's, cancer — we will look at them the way we look at the Black Death or smallpox today: relics of the past," Amodei told Dimon on Friday. "It sounds unrealistic. It sounds crazy. But I truly believe it. I truly believe it can be done."

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment